What investor type does ARK Genomic Revolution ETF fit best in FoxScore?

ARK Genomic Revolution ETF shows a mixed profile: trend is strongest, but stability lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.

How meaningful is the available history for ARK Genomic Revolution ETF?

ARK Genomic Revolution ETF currently has about 11.3 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for ARK Genomic Revolution ETF

ARKG · As of: 02/17/2026

Basic information

Type: ETF

Region: US

Sector: Health Care

TER: –

History

Available history:11.3 years

Last tradingday:02/17/2026

Description & usage

The ARK Genomic Revolution ETF is a thematic fund focused on genomics and biotechnology. It typically invests in areas such as gene sequencing, diagnostics, gene therapy, gene editing and precision medicine. Returns can be highly sensitive to R&D progress, clinical trial outcomes, approvals, reimbursement rules and funding cycles. As a result, volatility can be substantial and often higher than broad health-care ETFs. The ETF is used to gain targeted exposure to the genomics/biotech innovation theme.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

ARK Genomic Revolution ETF (ARKG) currently has a total score of 24 points, placing it in the weak range. The score is made up of Performance (22), Stability (18) and Trend (37). All three sub-scores are currently below average.

Performance scores 22 points (weak). Least weak metric: 1Y return at 4.1 %. Main drag: 5Y return at -74.3 %. This points to a sharper upswing more recently.

Stability scores 18 points (very weak). Least weak metric: return/volatility ratio at 0.09. Main drag: max drawdown (3Y) at -80.2 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 37 points (weak). Trend signals are mostly negative right now. Key strength: 12M momentum at 15.9 %. Main drag: Price is about 5.6 % below SMA50.

Overall, the score is shaped most by Trend; Stability trails and dampens the total. On a metric level, 12M momentum stands out, while 5Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

weak

Scores

Metrics

FAQ

What investor type does ARK Genomic Revolution ETF fit best in FoxScore?: ARK Genomic Revolution ETF shows a mixed profile: trend is strongest, but stability lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.
How meaningful is the available history for ARK Genomic Revolution ETF?: ARK Genomic Revolution ETF currently has about 11.3 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.